This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2005 Apr 20;23(12):2870-1; author reply 2871.

doi: 10.1200/JCO.2005.05.241.

Time for reappraisal of progesterone-receptor testing in breast cancer management

Gaëtan MacGrogan, Isabelle de Mascarel, Ghyslaine Sierankowski, Louis Mauriac, Marc Debled, Michel Durand, Christine Tunon De Lara, Antoine Avril, Véronique Picot, Simone Mathoulin-Pélissier

PMID: 15838009
DOI: 10.1200/JCO.2005.05.241

Comment

Time for reappraisal of progesterone-receptor testing in breast cancer management

Gaëtan MacGrogan et al. J Clin Oncol. 2005.

. 2005 Apr 20;23(12):2870-1; author reply 2871.

doi: 10.1200/JCO.2005.05.241.

Authors

Gaëtan MacGrogan, Isabelle de Mascarel, Ghyslaine Sierankowski, Louis Mauriac, Marc Debled, Michel Durand, Christine Tunon De Lara, Antoine Avril, Véronique Picot, Simone Mathoulin-Pélissier

PMID: 15838009
DOI: 10.1200/JCO.2005.05.241

No abstract available

PubMed Disclaimer

Comment on

Tree-based model for breast cancer prognostication.
Banerjee M, George J, Song EY, Roy A, Hryniuk W. Banerjee M, et al. J Clin Oncol. 2004 Jul 1;22(13):2567-75. doi: 10.1200/JCO.2004.11.141. J Clin Oncol. 2004. PMID: 15226324

Similar articles

Time to stop progesterone receptor testing in breast cancer management.
Olivotto IA, Truong PT, Speers CH, Bernstein V, Allan SJ, Kelly SJ, Lesperance ML. Olivotto IA, et al. J Clin Oncol. 2004 May 1;22(9):1769-70. doi: 10.1200/JCO.2004.99.251. J Clin Oncol. 2004. PMID: 15118010 No abstract available.
It is not time to stop progesterone receptor testing in breast cancer.
Colomer R, Beltran M, Dorcas J, Cortes-Funes H, Hornedo J, Valentin V, Vargas C, Mendiola C, Ciruelos E. Colomer R, et al. J Clin Oncol. 2005 Jun 1;23(16):3868-9; author reply 3869-70. doi: 10.1200/JCO.2005.05.203. J Clin Oncol. 2005. PMID: 15923595 No abstract available.
Progesterone receptor testing: not the right time to be buried.
Colozza M, Larsimont D, Piccart MJ. Colozza M, et al. J Clin Oncol. 2005 Jun 1;23(16):3867-8; author reply 3869-70. doi: 10.1200/JCO.2005.05.167. J Clin Oncol. 2005. PMID: 15923594 No abstract available.
[Prediction of therapeutic response in breast carcinoma: predictive factors].
Nesković-Konstantinović Z. Nesković-Konstantinović Z. Srp Arh Celok Lek. 1999 Mar-Apr;127(3-4):131-6. Srp Arh Celok Lek. 1999. PMID: 10500437 Review. Serbian. No abstract available.
[Estrogen and progesterone receptors in breast cancer].
Cohen Y, Borovik R. Cohen Y, et al. Harefuah. 1985 Dec 1;109(11):350-2. Harefuah. 1985. PMID: 3912300 Review. Hebrew. No abstract available.

See all similar articles

Cited by

Clinicopathological characteristics and prognostic analysis of breast cancer with a hormone receptor status of ER(-)/PR(+).
Wang X, Xue Y. Wang X, et al. Front Endocrinol (Lausanne). 2023 Jul 19;14:1193592. doi: 10.3389/fendo.2023.1193592. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37538790 Free PMC article.
Prognostic Significance of Single Progesterone Receptor Positivity: A Comparison Study of Estrogen Receptor Negative/Progesterone Receptor Positive/Her2 Negative Primary Breast Cancer With Triple Negative Breast Cancer.
Fan Y, Ding X, Xu B, Ma F, Yuan P, Wang J, Zhang P, Li Q, Luo Y. Fan Y, et al. Medicine (Baltimore). 2015 Nov;94(46):e2066. doi: 10.1097/MD.0000000000002066. Medicine (Baltimore). 2015. PMID: 26579819 Free PMC article.
A prospective cohort study of clinical characteristics and outcomes in Chinese patients with estrogen receptor-negative/progesterone receptor-positive early breast cancer.
Fan Y, Zhong X, Wang Y, Wang Z, Luo T, Wang Y, Zheng H. Fan Y, et al. Breast Cancer Res Treat. 2023 Jul;200(2):171-182. doi: 10.1007/s10549-023-06964-6. Epub 2023 May 18. Breast Cancer Res Treat. 2023. PMID: 37199804 Free PMC article.
Progesterone receptor expression is an independent prognostic variable in early breast cancer: a population-based study.
Purdie CA, Quinlan P, Jordan LB, Ashfield A, Ogston S, Dewar JA, Thompson AM. Purdie CA, et al. Br J Cancer. 2014 Feb 4;110(3):565-72. doi: 10.1038/bjc.2013.756. Epub 2013 Dec 3. Br J Cancer. 2014. PMID: 24300977 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information
Research Materials
- NCI CPTC Antibody Characterization Program